Therefore, selective loss of ADAR2 in MNs is sufficient to produce an ALS-like phenotype in vivo, while ensuring arginine inclusion in GluR2 ameliorates features of disease. Here, GRIA2 is linked to amyotrophic lateral sclerosis.